- Home
- ROIV vs UFPI Comparison
ROIV vs UFPI Comparison
Compare ROIV & UFPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- UFPI
- Stock Information
- Founded
- ROIV 2014
- UFPI 1955
- Country
- ROIV United Kingdom
- UFPI United States
- Employees
- ROIV N/A
- UFPI N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- UFPI Forest Products
- Sector
- ROIV Health Care
- UFPI Basic Materials
- Exchange
- ROIV Nasdaq
- UFPI Nasdaq
- Market Cap
- ROIV 8.4B
- UFPI 7.4B
- IPO Year
- ROIV N/A
- UFPI 1993
- Fundamental
- Price
- ROIV $12.30
- UFPI $113.03
- Analyst Decision
- ROIV Strong Buy
- UFPI Buy
- Analyst Count
- ROIV 10
- UFPI 5
- Target Price
- ROIV $17.33
- UFPI $129.00
- AVG Volume (30 Days)
- ROIV 4.2M
- UFPI 218.5K
- Earning Date
- ROIV 08-08-2024
- UFPI 10-29-2024
- Dividend Yield
- ROIV N/A
- UFPI 1.17%
- EPS Growth
- ROIV N/A
- UFPI N/A
- EPS
- ROIV 5.65
- UFPI 7.72
- Revenue
- ROIV $158,303,000.00
- UFPI $6,892,915,000.00
- Revenue This Year
- ROIV $45.51
- UFPI N/A
- Revenue Next Year
- ROIV $42.29
- UFPI $6.08
- P/E Ratio
- ROIV $2.18
- UFPI $14.65
- Revenue Growth
- ROIV 101.44
- UFPI N/A
- 52 Week Low
- ROIV $8.25
- UFPI $90.62
- 52 Week High
- ROIV $13.24
- UFPI $136.93
- Technical
- Relative Strength Index (RSI)
- ROIV 65.79
- UFPI 38.87
- Support Level
- ROIV $11.50
- UFPI $118.49
- Resistance Level
- ROIV $12.60
- UFPI $122.00
- Average True Range (ATR)
- ROIV 0.35
- UFPI 2.91
- MACD
- ROIV 0.04
- UFPI -0.94
- Stochastic Oscillator
- ROIV 79.19
- UFPI 4.12
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About UFPI UFP Industries Inc.
UFP Industries Inc is a supplier of lumber to the manufactured housing industry. Today UFP Industries is a multibillion-dollar holding company with subsidiaries around the globe that serve three markets: retail, packaging and construction.